[go: up one dir, main page]

MX2010005699A - Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. - Google Patents

Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos.

Info

Publication number
MX2010005699A
MX2010005699A MX2010005699A MX2010005699A MX2010005699A MX 2010005699 A MX2010005699 A MX 2010005699A MX 2010005699 A MX2010005699 A MX 2010005699A MX 2010005699 A MX2010005699 A MX 2010005699A MX 2010005699 A MX2010005699 A MX 2010005699A
Authority
MX
Mexico
Prior art keywords
capsid protein
papilloma virus
human papilloma
major capsid
genes encoding
Prior art date
Application number
MX2010005699A
Other languages
English (en)
Inventor
Gaoxia Zhang
Qiong Shen
Jianqiang Lei
Jingyu Yuan
Menghua Zhang
Qianli Zhang
Yinghua Xiong
Roger Wei
Ke Wu
Original Assignee
Shanghai Zerun Biotechnology C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 200710170935 external-priority patent/CN101440372B/zh
Priority claimed from CN200710170934A external-priority patent/CN101440371B/zh
Priority claimed from CN200710170936A external-priority patent/CN101440373B/zh
Priority claimed from CN2008100326547A external-priority patent/CN101487009B/zh
Priority claimed from CN200810032655A external-priority patent/CN101487010B/zh
Application filed by Shanghai Zerun Biotechnology C filed Critical Shanghai Zerun Biotechnology C
Publication of MX2010005699A publication Critical patent/MX2010005699A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Genes de codón optimizado que codifican la importante proteína de cápside L1del virus del papiloma humano; se puede expresar estos genes en la importante proteína de cápside L1 del virus del papiloma humano después de ser trasducida a células de levadura con alta eficiencia; se provee una macromolécula con inmunogenicidad, que se produce por expresión de los genes de codón optimizado que codifican la importante proteína de cápside L1 del virus del papiloma humano en células de levadura, los usos y la composición de la misma.
MX2010005699A 2007-11-23 2008-11-24 Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. MX2010005699A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CN 200710170935 CN101440372B (zh) 2007-11-23 2007-11-23 一种18型人乳头状瘤病毒主要衣壳蛋白l1基因
CN200710170934A CN101440371B (zh) 2007-11-23 2007-11-23 一种16型人乳头状瘤病毒主要衣壳蛋白l1基因
CN200710170936A CN101440373B (zh) 2007-11-23 2007-11-23 一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因
CN2008100326547A CN101487009B (zh) 2008-01-15 2008-01-15 用毕赤酵母表达系统制备抗人乳头瘤病毒16型感染的疫苗的方法
CN200810032655A CN101487010B (zh) 2008-01-15 2008-01-15 用毕赤酵母表达系统制备抗人乳头瘤病毒18型感染的疫苗的方法
PCT/CN2008/073167 WO2009076824A1 (zh) 2007-11-23 2008-11-24 人乳头状瘤病毒主要衣壳蛋白l1基因及其用途

Publications (1)

Publication Number Publication Date
MX2010005699A true MX2010005699A (es) 2010-09-14

Family

ID=40795163

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010005699A MX2010005699A (es) 2007-11-23 2008-11-24 Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos.
MX2014002449A MX344751B (es) 2007-11-23 2008-11-24 Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2014002449A MX344751B (es) 2007-11-23 2008-11-24 Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos.

Country Status (9)

Country Link
US (2) US8795676B2 (es)
EP (3) EP2479187A1 (es)
KR (1) KR101588413B1 (es)
CN (1) CN101835797A (es)
BR (1) BRPI0818957B8 (es)
MX (2) MX2010005699A (es)
MY (2) MY182347A (es)
RU (1) RU2494106C2 (es)
WO (1) WO2009076824A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104745605B (zh) * 2013-12-26 2020-02-07 上海泽润生物科技有限公司 重组人乳头瘤病毒6和11亚型蛋白毕赤酵母表达
CN117187262A (zh) * 2014-02-18 2023-12-08 上海泽润生物科技有限公司 重组人乳头瘤病毒蛋白表达
EP3191505A2 (en) * 2014-09-11 2017-07-19 Cadila Healthcare Limited Superior human papilloma virus antigens with superior immunological properties and vaccine containing it
CN106893730B (zh) * 2015-12-18 2021-06-11 上海泽润生物科技有限公司 重组人乳头瘤蛋白表达
JOP20190242A1 (ar) * 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها
CN117110606B (zh) * 2023-08-21 2024-06-04 广东省一鼎生物技术有限公司 一种基于竞争法检测hpv不同型别中和抗体的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1471147A3 (en) * 1991-07-19 2007-03-21 The University Of Queensland Method of making a recombinant molecule for the expression of HPV-16 L1 protein
US5747663A (en) * 1994-02-07 1998-05-05 Qiagen Gmbh Process for the depletion or removal of endotoxins
CN1152935A (zh) * 1994-05-16 1997-06-25 麦克公司 乳头状瘤病毒疫苗
AU4270196A (en) * 1994-10-07 1996-05-02 Lutz Gissmann Papilloma virus-like particles, fusion proteins and process for producing the same
US6436402B1 (en) * 1999-10-15 2002-08-20 Merck & Co., Inc. Process for making human papillomavirus virus-like particles with improved properties
DE10055545A1 (de) * 2000-11-09 2002-07-25 Deutsches Krebsforsch Für Expression in Eukaryonten optimierte HPV 16-L1 und HPV 16-L2 kodierende DNA Sequenzen
JP4505452B2 (ja) * 2003-03-24 2010-07-21 メルク・シャープ・エンド・ドーム・コーポレイション 酵母におけるｈｐｖ３１ｌ１の最適化発現
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
MY148656A (en) 2004-03-24 2013-05-15 Merck Sharp & Dohme Optimized expression of hpv 52 l1 in yeast.
CN100392084C (zh) * 2006-03-13 2008-06-04 曾毅 含密码子优化型hpv16l1基因的重组腺病毒

Also Published As

Publication number Publication date
EP2479186B1 (en) 2015-08-12
KR20100102114A (ko) 2010-09-20
MY162658A (en) 2017-06-30
EP2223933B1 (en) 2016-01-27
US9034340B2 (en) 2015-05-19
US8795676B2 (en) 2014-08-05
RU2494106C2 (ru) 2013-09-27
BRPI0818957A2 (pt) 2019-12-17
BRPI0818957B1 (pt) 2021-05-04
MX344751B (es) 2017-01-05
RU2010125695A (ru) 2011-12-27
EP2223933A4 (en) 2012-01-04
CN101835797A (zh) 2010-09-15
US20110256182A1 (en) 2011-10-20
US20140328935A1 (en) 2014-11-06
EP2479187A1 (en) 2012-07-25
BRPI0818957B8 (pt) 2021-05-25
EP2479186A1 (en) 2012-07-25
EP2223933A1 (en) 2010-09-01
MY182347A (en) 2021-01-20
WO2009076824A1 (zh) 2009-06-25
KR101588413B1 (ko) 2016-02-02

Similar Documents

Publication Publication Date Title
MX344751B (es) Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos.
EP3444352A3 (en) Production of recombinant vaccine in e. coli by enzymatic conjugation
EA201190327A1 (ru) Новые конструкции белка вируса папилломы человека (hpv) и их применение в предупреждении заболевания, вызываемого hpv
WO2006060314A3 (en) Generation of replication competent viruses for therapeutic use
ECSP056032A (es) Expresión optimizada de hpv 31 l1 en levadura
WO2008034388A8 (en) Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
EP2388270A3 (en) Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
MY140664A (en) Optimized expression of hpv 45 l1 in yeast
MX2010003713A (es) Vacunas de citomegalovirus y metodos de produccion.
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
WO2011142865A3 (en) Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids
NZ712943A (en) Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
MX2009013188A (es) Metodos para producir productos de fermentacion.
WO2009020144A1 (ja) 異種タンパク質の製造方法
WO2009099877A3 (en) Closterovirus vectors and methods
NZ611531A (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
DK2608806T3 (da) Epstein-barr-virusvaccine
WO2010079991A3 (ko) 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균
WO2024044723A8 (en) Engineered retrons and methods of use
PL2040560T3 (pl) Granulki cysteinowe i ich zastosowanie jako stymulatora wzrostu Bifidobacterium animalis lactis
NZ599479A (en) Improved reverse genetics methods for virus rescue
NZ578959A (en) Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
WO2009088950A3 (en) Pcv2 orf2 virus like particle with foreign amino acid insertion
AR069884A1 (es) Metodos para empacar vectores de virus de estomatitis vesicular de propagacion defectuosa
NZ606949A (en) Human papillomavirus e7 antigen compositions and uses thereof

Legal Events

Date Code Title Description
FG Grant or registration